A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2006
11/08/2006	CN1283241C Medicine for trichomonas vaginalis disease
11/08/2006	CN1283240C Pharmaceutical use of COX-2 inhibitors in angiogenesis-mediated ocular disorders
11/08/2006	CN1283239C 1-amino-alkylcyclohexanes as trypanocidal agents
11/08/2006	CN1283238C Use of alkannin in preparing medicine for treating tumor disease
11/08/2006	CN1283237C Curcumin and phosphatide composite and its preparation method
11/08/2006	CN1283236C Application of Hehoupu phenol in preparing antitumour multi medicinal tolerant medicine
11/08/2006	CN1283235C Clear and stable propofol composition
11/08/2006	CN1283229C New self emulsifying drug delivery system
11/08/2006	CN1283215C Biodegradable vehicles and delivery systems of biologically active substances
11/08/2006	CN1283151C Synergic microbiocidal composition
11/07/2006	USRE39384 Substituted thiazolidinedione derivatives
11/07/2006	US7132570 Method for the production of crystalline forms and crystalline forms of optical enantiomers of modafinil
11/07/2006	US7132568 beta-amino amides; treating degenerative dementias characterized by beta-amyloid deposits in the brain, especially Alzheimer's Disease
11/07/2006	US7132554 Synergistic mixture of an orally administered taxane compound and the epidermal growth factor receptor antibody, cetuximab; especially for treaing colorectal cancer, breast cancer, gastric cancer, ovarian cancer, non-small cell lung cancer and cancers of the head and neck.
11/07/2006	US7132553 Inhibitor is a (2-amino-(optionally -1-oxo)-3-thiopropyl)--5,6,7,8-tetrahydroimidazo[1,2a]pyrazine derivative or its disulfide dimer, e.g., (2-amino-1-oxo-3-thiopropyl)-8-(cyclohexylmethyl)-2-phenyl-5,6,7,8-tetrahydroimidazo[1,2a]pyrazine
11/07/2006	US7132552 Reacting aminobutanamide hydrochloride with chlorobutyl chloride in solvent such as acetonitrile and methyl tert-butyl ether in base
11/07/2006	US7132551 Piperidine and azepine derivatives; anxiolytic, analgesic, antidepressant, antiemetic, antiinflammatory, and hypotensive agents; sexual and psychological disorders; Alzheimers, Parkinsons, Lesche-Nyhane, Wilsons, and Tourettes syndrome
11/07/2006	US7132547 Preventives/remedies for urinary disturbance
11/07/2006	US7132546 Aniline derivatives or salts thereof and cytokine production inhibitors containing the same
11/07/2006	US7132542 Compounds for the treatment of male erectile dysfunction
11/07/2006	US7132539 Melanocortin receptor ligands
11/07/2006	US7132537 Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states
11/07/2006	US7132533 Tricyclic compounds protein kinase inhibitors for enhancing the efficacy of anti-neoplastic agents and radiation therapy
11/07/2006	US7132532 Compounds useful in the manufacture of an anti-inflammatory androstane derivative
11/07/2006	US7132529 Antisense modulation of stearoyl-CoA desaturase expression
11/07/2006	US7132513 Bifunctional chelating agent
11/07/2006	US7132458 Oxidized carotenoid fractions and ketoaldehyde useful as cell-differentiation inducers, cytostatic agents, and anti-tumor agents
11/07/2006	US7132457 Adamantane derivatives
11/07/2006	US7132456 MCH receptor antagonists
11/07/2006	US7132454 HEXIM1 as a suppressor of HIV replication and cardiac hypertrophy
11/07/2006	US7132453 Administering infection moderator
11/07/2006	US7132452 Useful for threapy of pain/inflammation associated with infection caused by herpes virus, especially herpes simplex virus (HSV) and varicella-zoster virus (VZV)
11/07/2006	US7132451 Inhibition of TNF-α-initiated neutrophil response
11/07/2006	US7132450 Hepatic disorder suppressant
11/07/2006	US7132449 useful for the therapeutic treatment of Trypanosoma cruzi infection
11/07/2006	US7132447 Substance FKI-1083 and process for producing the same
11/07/2006	US7132446 Administering epicatechin-galloyl-epicatechin-gallate (B2-di-gallate) to a patient as vasorelaxant
11/07/2006	US7132445 Antiinflammatory agents; anticancer agents; analgesics; antiarthritic agents; inflammatory bowel disorders; respiratory system disorders
11/07/2006	US7132444 Process for the preparation of trans-3-ethyl-2,5-dihydro-4-methyl-N-[2-[4-[[[[(4-methyl cyclohexyl) amino]carbonyl]amino]sulfonyl] phenyl]ethyl]-2-oxo-1H-pyrrole-1-carboxamide
11/07/2006	US7132443 Fluoropyrrolidines as dipeptidyl peptidase inhibitors
11/07/2006	US7132442 6H-thieno[2, 3-b]pyrrole derivatives as antagonists of gonadotropin releasing hormone (GnRH)
11/07/2006	US7132441 Administering therapeutically-effective amount of a 5-lipoxygenase inhibitor and a cyclooxygenase-2 inhibitor selected from Dupont Dup 697, Taisho NS-398, meloxicam, flosulide and heterocyclic compounds
11/07/2006	US7132440 such as 2-[4-(2-Phenyl-[1,3]dioxolan-2-yl)-phenyl]-1H-benzoimidazole-5-carboxylic acid amide; for treatment of cancer
11/07/2006	US7132439 Bis-benzimidazoles and related compounds as potassium channel modulators
11/07/2006	US7132438 Benzimidazole derivatives
11/07/2006	US7132437 for example, methyl 4'-[(3,5-dibutyl-1H-1,2,4-triazol-1-yl)methyl][1,1'-biphenyl]-2-carboxylate; for treatment of congestive heart failure
11/07/2006	US7132436 Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1
11/07/2006	US7132435 Syn-1H-indazole-3-carboxylic acid (4-{[2-(2,3-dihydro-benzo[b]thiophen-6-yloxy)-5-fluoro-pyridine-3-carbonyl]amino}-cyclohexyl)-amide; useful as cyclic nucleotide phosphodiesterase-4 ( PDE-4 ) inhibitor
11/07/2006	US7132434 N-[(3S)-1-hydroxy-2-oxopyrrolidinyl]-N-methyl-4'-(trifluoromethyl)[1,1'-biphenyl]-4-sulfonamide or derivatives to treat Respiratory system disorders; arthritis, and bone disorders
11/07/2006	US7132433 Use of (+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4- piperidinemethanol or its prodrug in the treatment of behavioral or psychological symptoms associated with a disease
11/07/2006	US7132432 Antiinflammatory agents; vision defects; autoimmune diseases; hepatitis; cardiovascular disordersl chronic fatigue syndromel chronic ostructive pulmonary disease; congestive heart failure
11/07/2006	US7132431 Anti-malarial compounds
11/07/2006	US7132430 Treatment of cardiovascular and related pathologies
11/07/2006	US7132429 Sulfonamido ether substituted imidazoquinolines
11/07/2006	US7132428 5-pyridin-2-yl-3-trifluoromethyl-1H-pyrazolo[4,3-c]isoquionoline; useful for treating osteoarthritis, rheumatoid arthritis and asthma
11/07/2006	US7132427 Quinazolines and uses thereof
11/07/2006	US7132426 Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
11/07/2006	US7132425 5-substituted-six-membered heteroaromatic glucokinase activators
11/07/2006	US7132424 Monocyclic derivatives as matrix metalloproteinase inhibitors
11/07/2006	US7132423 e.g., N-Cycloheptyl-N'(1-ethyl-pyrrolidin-2-ylmethyl)-6-(3-fluoro-4-methoxy-phenoxy)-[1,3,5]triazine-2,4-diamine; treating unwanted cellular proliferation, an inflammation mediated disease, or a hyperproliferative disease, or modulating a glycosidase enzyme
11/07/2006	US7132422 An aromatic-oxy-alkyleneamine derivative, useful for treating neuropathic pain
11/07/2006	US7132421 Antiproliferative agnets
11/07/2006	US7132420 Aspartic protease inhibitors
11/07/2006	US7132419 Benzo[a]phenazine-11-carboxamide derivative used as fungicide, bactericide, inhibitors of topoisomerase for treating cancer
11/07/2006	US7132417 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents
11/07/2006	US7132416 Benzothiazepine and benzothiazepine derivatives with ileal bile acid transport (IBAT) inhibotory activity for the treatment hyperlipidaemia
11/07/2006	US7132415 Especially a substituted azetidinone compound
11/07/2006	US7132414 Pharmaceutical compositions containing 3-aminoazetidine derivatives, novel derivatives and their preparation
11/07/2006	US7132413 Contacting liquid contacting surface of drug delivery system with a thrombosis-preventing liquid containing taurolidine, taurultam or a mixture and an anticoagulant agent other than taurolidine and taurultam
11/07/2006	US7132412 Treatment of skin diseases using a pharmaceutical preparation in colloidal form
11/07/2006	US7132409 2-(6-cyano-1-hexyn-1-yl)adenosine; 2(6-cyano-1-hexyn-1yl)adenosine 5' phosphate or salts; for lowering ocular tension, promoting blood flow in retina, protecting optic nerve failure; for treament of glaucoma and ocular hypertension
11/07/2006	US7132408 Composition and method for inhibiting platelet aggregation
11/07/2006	US7132407 N'-neu-IL-2 fusion gene controlled by a cytomegalo virus promoter
11/07/2006	US7132406 Stimulation of cellular regeneration and differentiation in the inner ear
11/07/2006	US7132405 Targeting vector to the urokinase plasminogen activator receptor
11/07/2006	US7132404 Liposome, a ligand and a polymeric scaffold; ligand can bind to a cell surface receptor or molecule expressed by the target cell
11/07/2006	US7132403 Antihelminthic anthraquinones and method of use thereof
11/07/2006	US7132402 Administering N-{2-Chloro-5-[(2,2',3,3',4',6,6')-hepta-O-acetyl- beta -D-maltosyl-oxymethyl]-phenyl}-(9H-fluoren-9-ylmethoxycarbonyl)-L-alaninamide or a salt or other derivatives of acylated benzylmaltosides to treat restenosis in a mammal
11/07/2006	US7132400 Exposing the cancer cell to a peptide has antiestrotrophic activity and is eight to twenty amino acids long; use of tamoxifen therapy in combination with the peptide therapy
11/07/2006	US7132397 Bone morphogenetic protein antagonist based on the mature protein
11/07/2006	US7132287 Method for neural stem cell differentiation using 5HT-1A agonists
11/07/2006	US7132248 Uses of galanin GALR2 receptors
11/07/2006	US7132238 Method of determining a chemotherapeutic regimen based on ERCC1 expression
11/07/2006	US7132116 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds
11/07/2006	US7132114 Blending wih starch, lubricant, wetting agent; compression
11/07/2006	US7132112 Mixture with alcohol carrier; administering to drug nose mucous membrane; side effect reduction
11/07/2006	US7132111 reacting guaiacol and phenol with sulfuric acid and water to make a preselected concentration of preselected isomers of phenolsulfonic acid and guaiacolsulfonic acid; treating periodontal disease and canker sores; exfoliants for feet and faces.
11/07/2006	US7132096 Inhibiting enoyl reductase; altering pathway of fatty acid synthesis; screening
11/07/2006	CA2416879C Methods of treating cancer and the pain associated therewith using endothelin antagonists
11/07/2006	CA2400422C Lamellar structured cosmetic composition
11/07/2006	CA2375093C Delivery system for oral care compositions comprising organosiloxane resins using a removable backing strip
11/07/2006	CA2343270C Methazolamide compositions and method of use
11/07/2006	CA2306277C Dextran reduced in boron content, process for producing the same, and dextran packed in container in solution state
11/07/2006	CA2301176C Self-binding shearform compositions
11/07/2006	CA2281755C Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker
11/07/2006	CA2274093C Substituted pyrimidinone and pyridinone compounds and their use
11/07/2006	CA2261988C Mannose-6-phosphate composition and its use in treating fibrotic disorders
11/07/2006	CA2261802C Use of xanomeline for treating bipolar disorder
11/07/2006	CA2260943C Formulation of 5-ht agonists
11/07/2006	CA2252515C Pharmaceutical compositions for prevention and treatment of central nervous system disorders

1 ... 4021 4022 4023 4024 4025 4026 4027 4028 4029 4030 4031 4032 4033 4034 4035 4036 4037 4038 4039 4040 4041 ... 7860